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Summary
Helminth	parasites	induce	a	strong	Th2	response,	characterized	by	high	levels	of	IgE	
and	elevated	signature	cytokines	such	as	IL-	5.	As	many	global	deworming	programmes	
are	underway,	there	 is	concern	that	this	might	 lead	to	emergence	of	Th1-	mediated	
pathologies	 when	 the	 counterbalancing	 helminth-	induced	 Th2	 response	 is	 absent.	
Therefore,	 we	 assessed	 the	 effect	 of	 deworming	 on	 Th2-	mediated	 responses	 in	 a	
household-	clustered	 randomized	 controlled	 trial	 in	 Indonesia.	 Total	 plasma	 IgE	 and	
whole-	blood	IL-	5	responses	to	mitogen	phytohaemagglutinin	(PHA)	were	measured	in	
1494	and	682	subjects,	respectively,	at	baseline,	9	and	21	months	after	three-	monthly	
single-	dose	 treatment	with	albendazole	or	placebo.	Anthelmintic	 treatment	did	not	
result	in	complete	removal	of	helminth	infections	in	the	community.	However,	treat-
ment	significantly	decreased	IgE	levels	in	albendazole-	compared	to	placebo-	treated	
subjects.	IL-	5	responses	to	PHA	were	not	significantly	affected	by	anthelmintic	treat-
ment	and	tended	to	increase	in	albendazole-	treated	subjects,	indicating	that	intensive	
treatment	of	helminth	parasites	has	different	outcomes	on	B-	cell	(IgE	levels)	and	T-	cell	
(IL-	5)	 responses.	 The	 data	 shows	 that	 2	years	 of	 deworming	 can	 have	 differential	
	effects	on	responses	typified	as	Th2-	mediated,	which	needs	to	be	taken	into	account	
when examining the impact of helminths on noncommunicable diseases.
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1  | INTRODUCTION
Amongst	helminth	parasites,	soil-	transmitted	helminths	(STHs)	which	
reside	in	the	gut,	are	most	prevalent.	More	than	1.5	billion	people	are	
infected	with	STHs	worldwide,	and	 infections	are	widely	distributed	
in tropical and subtropical countries.1	Important	STHs	include	Ascaris 
lumbricoides, Trichuris trichiura	and	hookworm	(Ancylostoma duodenale 
and Necator americanus).
Helminth	parasites	are	the	most	potent	natural	stimuli	for	T	helper	
2	(Th2)	responses,	characterized	by	Th2	cytokines	(IL-	4,	IL-	5	and		IL-	13),	
eosinophilia	and	high	levels	of	IgE	antibodies.	Whereas	IL-	5	regulates	
eosinophilia,	IL-	4	and	IL-	13	promote	IgE	production	by	inducing	B-	cell	
switching	to	IgE-	producing	cells.
*Karin	de	Ruiter	and	Dicky	L.	Tahapary	contributed	equally	to	this	work.
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Th2	 responses	do	not	 solely	protect	 against	 helminth	 infections	
but also play an important role in the development of various inflam-
matory	diseases,	where	an	imbalance	between	Th1/Th2	cell	responses	
and	their	regulation	can	lead	to	pathogenesis.	Studies	in	animal	models	
and in humans have indicated that helminths might play a protective 
role in the development of allergies, autoimmunities and inflammatory 
bowel disease.2	Moreover,	recent	in	vivo	studies	showed	that	helminth	
infections	might	protect	against	insulin	resistance	as	helminth-	induced	
Th2	 responses	were	 associated	with	 improved	 glucose	 metabolism	
and insulin signalling in mice.3-6
This	has	raised	concern	regarding	the	implementation	of	deworm-
ing	 programmes,	 which	 might	 lead	 to	 emergence	 of	 Th1-	mediated	
pathologies.	The	 immunological	consequences	of	deworming	should	
therefore	be	examined	in	detail,	given	that	Th2	responses	consist	of	
multiple arms.
To	this	end,	we	analysed	the	immunological	data	obtained	from	a	
household-	based	cluster-	randomized	double-	blind	placebo-	controlled	
trial	 of	 three-	monthly	 single-	dose	 albendazole	 treatment	 in	 an	 area	
where	STHs	are	highly	endemic.7	This	 study	describes	 the	effect	of	
anthelmintic	 treatment	on	 two	different	components	of	 the	Th2	re-
sponse,	namely	total	IgE	levels	and	total	IL-	5	production	in	response	
to	a	polyclonal	stimulation	(phytohemagglutinin,	PHA).
2  | MATERIALS AND METHODS
2.1 | Study design
This	report	describes	a	nested	study	within	the	ImmunoSPIN	trial.8,9 
The	 trial	was	 conducted	 in	 2	 villages,	Nangapanda	 and	Anaranda,	
in	Ende	District,	Flores	Island,	Indonesia.	In	2008,	the	double-	blind	
placebo-	controlled	 trial	 of	 2	year	 duration	 was	 initiated	 by	 ran-
domizing	all	households	 to	 receive	either	a	 single	dose	of	400	mg	
albendazole	 or	 a	matching	 placebo	 every	 3	months	 over	 a	 2-	year	
study	period	(tablets	from	PT	Indofarma	Pharmaceutical,	Bandung,	
Indonesia).	Treatment	allocation	was	based	on	household	 to	mini-
mize	 the	 risk	 of	 cross-	contamination	 and	 therefore	 re	infection	 of	
treated	individuals.	Treatment	was	provided	to	all	household	mem-
bers older than 2 years of age, except for pregnant women. Drug 
intake	 was	 observed	 by	 field	 workers.	 The	 study	 was	 approved	
by	 the	 Ethical	 Committee	 of	 the	 Medical	 Faculty,	 University	 of	
Indonesia,	 Jakarta	 (ref:	 194/PT02.FK/Etik/2006),	 and	 has	 been	
filed	 by	 the	 Ethics	 Committee	 of	 the	 Leiden	 University	 Medical	
Center,	 the	 Netherlands.	 The	 trial	 was	 registered	 as	 clinical	 trial	
(ISRCTN83830814).	Informed	consent	or	parental	consent	was	ob-
tained from all participants.
2.2 | Study population
The	randomization	for	the	total	study	was	based	on	954	households	
comprising of 4 004 individuals in the 2 villages, resulting in 2 022 
(481	 houses)	 and	 1	982	 (473	 houses)	 subjects	 in	 the	 placebo	 and	
albendazole	 group,	 respectively,	 as	 described	 before.7	 The	 current	
study	included	1	762	(363	houses)	and	1	731	(362	houses)	subjects	
in	 the	placebo	and	albendazole	group	 in	 the	village	of	Nangapanda	
respectively	 (Fig.	 S1).	 At	 baseline,	 blood	 samples	 from	 2	349	 sub-
jects were collected to analyse total IgE levels and after inclusion of 
subjects	 with	 at	 least	 one	 follow-	up	 blood	 sample,	 1	494	 subjects	
were	 included	 at	 baseline,	 corresponding	 to	753	placebo-	 and	741	
albendazole-	treated	individuals.
To	 study	 immunological	 responses,	 250	 households	 were	 ran-
domly selected and individuals older than 4 years of age were invited 
for morning venous blood sampling and assessment of anthropometric 
parameters.	This	resulted	in	the	inclusion	of	882	individuals,	of	which	
858	provided	sufficient	blood	samples	for	whole-	blood	cultures.	After	
inclusion	of	subjects	with	at	 least	baseline	and	one	follow-	up	blood	
sample, we ended up with 682 subjects at baseline, corresponding to 
374	placebo-	and	308	albendazole-	treated	individuals	(Fig.	S1).	As	this	
is	a	nested	immunology	study,	86%	(584	of	682)	of	the	subjects	were	
also part of the group of 1 494 subjects included for the analysis of 
IgE levels.
2.3 | Parasitological examination
Yearly	stool	samples	were	collected	to	examine	the	effect	of	treat-
ment on helminth prevalence. T. trichiura was detected by micros-
copy	 after	 formol-	ether	 concentration,	 and	 18S-	based	 multiplex	
real-	time	 PCR	 was	 used	 for	 the	 specific	 amplification	 and	 detec-
tion	of	hookworm	 (A. duodenale, N. americanus), A. lumbricoides and 
S. stercoralis	 DNA,	 as	 described	 previously.9	 PCR	 output	 was	 ex-
pressed	 as	 the	 cycle	 threshold	 (Ct)	 reflecting	 the	 load	of	parasite-	
specific	DNA	 in	 the	 sample	 tested.	Parasite-	specific	DNA	 loads	of	
A. duodenale, N. americanus and A. lumbricoides	were	categorized	as	
low	load	(Ct≥30)	and	high	load	(Ct<30),	irrespective	of	infection	with	
T. trichiura	of	which	only	microscopy	data	were	available.	A	subject	
was	defined	to	have	a	heavy	infection	when	a	high	DNA	load	(Ct<30)	
was	 measured	 for	 either	 hookworm	 or	 A. lumbricoides, whereas a 
light	 infection	 refers	 to	 subjects	 with	 low	 DNA	 loads	 (Ct≥30)	 for	
both of these helminth species, including subjects that are helminth 
negative.
2.4 | Plasma IgE
The	levels	of	total	IgE	were	measured	by	ELISA	in	Jakarta	as	described	
previously.9	The	results	are	expressed	in	international	units	(IU/mL).
2.5 | Whole- blood culture and IL- 5 measurements
Whole	blood	was	stimulated	in	vitro	as	described	before.9,10	Cultures	
were stimulated for 72 hours to detect adaptive responses to phyto-
haemagglutinin	(PHA,	2	μg/mL,	Wellcome	Diagnostics,	Dartford,	UK),	
and unstimulated control wells were included. Due to budget restric-
tions,	we	could	only	measure	one	Th2	cytokine	and	opted	 for	 IL-	5.	
Supernatants	were	 stored	 at	 −20°C	 until	 IL-	5	was	 quantified	 using	
Luminex	 cytokine	 kits	 (Biosource,	 Camarillo,	 USA)	 on	 a	 LiquiChip	
200®	 Workstation	 (Qiagen,	 Venlo,	 the	 Netherlands)	 equipped	
with	 LiquiChip	 analyser	 software	 (Qiagen,	 Venlo,	 the	 Netherlands).	
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Cytokine	levels	that	fell	below	the	assay’s	detectable	range	were	re-
placed by half of the detection limit provided by the manufacturer.
2.6 | Statistical analysis
The	 total	 IgE	 and	 cytokine	 data	 were	 log-	transformed	 to	 obtain	 a	
normally	distributed	variable.	Cross-	sectional	 comparisons	between	
groups	at	baseline	were	tested	with	Student’s	t	test.	To	assess	treat-
ment	effects,	generalized	linear	mixed	models	were	used	with	addition	
of	three	random	effects,	namely	a	random	household-	specific	inter-
cept	 to	model	 clustering	within	 households	 and	 a	 random	 subject-	
specific intercept and slope to model correlation within subjects, as 
previously described.10 Parameter estimates for treatment effects at 
9 and 21 months and 95% confidence intervals are reported, as well 
as interaction P-	values	when	a	subgroup	analysis	was	performed.	The	
reported P-	values	are	obtained	using	 likelihood	 ratio	 tests	by	com-
paring	the	model	with	and	without	the	treatment	effect.	All	models	
were	fitted	using	the	lme4	package.11	The	analysis	was	intention	to	
treat and involved all participants as assigned randomly at the start 
of the trial.
3  | RESULTS
3.1 | Study population
Baseline	characteristics	of	the	study	participants	are	shown	in	Table	1.	
At	baseline,	84.8%	of	the	individuals	were	infected	with	one	or	more	
helminth	species,	with	hookworm	infections	being	the	most	prevalent	
(73.1%	of	 total).	At	baseline,	 total	 IgE	 levels	 and	 IL-	5	production	 in	
response	 to	PHA	were	 similar	 in	both	 treatment	 arms.	The	consort	
diagram	of	the	study	is	shown	in	Fig.	S1.	Subjects	were	included	in	the	
analysis	when	data	from	baseline	and	at	least	one	of	the	two	follow-	up	
time points were available.
3.2 | Effect of albendazole treatment on 
helminth prevalence
Similar	to	the	major	study,7 subset analysis in this study revealed that in-
tensive	treatment	with	albendazole	resulted	in	a	reduction	in	STHs	both	
after	9	 (percentage	 infected:	49.9%	for	albendazole	vs.	80.5%	for	pla-
cebo)	and	after	21	months	of	treatment	(39.9%	for	albendazole	vs.	75.4%	
for	placebo;	Figure	1A).	Albendazole	had	the	largest	effect	on	hookworm	
(from	74.4%	at	baseline	to	29.0%	at	9	months	and	20.7%	at	21	months	of	
treatment)	compared	to	placebo	(from	71.8%	to	66.7%	to	62.1%	respec-
tively).	This	was	followed	by	A. lumbricoides	(albendazole	from	33.3%	to	
14.5%	and	10.1%;	placebo	from	35.1%	to	33.6%	and	32.1%),	while	the	
effect on T. Trichiura	was	much	less	pronounced	(albendazole	from	27.7%	
to	22.0%	and	18.2%;	placebo	from	25.8%	to	30.0%	and	25.9%).
3.3 | Baseline IgE levels
Baseline analysis of total IgE in subjects with light and heavy infec-
tions,	as	defined	in	Materials	and	Methods	(section	2.3),	revealed	that	
higher infection intensity was associated with significantly elevated 
IgE	 levels	 (light	 infection:	809	 (695-	940)	 IU/mL	 [GM,	95	CI],	 heavy	
infection:	1544	(1376-	1732)	IU/mL,	P<.001)	(Table	S1).	Polyclonal	IgE	
levels	were	 significantly	 lower	 in	 adults	 (1185	 (1086-	1294)	 IU/mL)	
compared	to	children	≤	19	years	(1766	(1561-	1999)	IU/ml)	(P<.001),	
whereas	 no	 significant	 difference	was	 found	 between	males	 (1307	
(1189-	1437)	IU/mL)	and	females	(1434	(1283-	1603)	IU/mL)	(P=.219).
3.4 | Effect of albendazole treatment on plasma 
IgE levels
Figure	1B	presents	the	estimated	effect	of	treatment	on	total	IgE	lev-
els	after	9	and	21	months.	Total	 IgE	 levels	were	significantly	 lower	
after	9	and	21	months	 in	 the	albendazole-	treated	group	 (estimates	
N Placebo N Albendazole
Age	(mean	in	y,	SD) 753 32.2	(18.7) 741 32.4	(19.0)
Sex	(female,	n,	%	of	total) 753 459	(61.0) 741 445	(60.0)
BMI>19	y	old	(mean,	SD) 490 22.5	(4.0) 486 21.9	(3.7)
Z	score	of	BMI≤19y	old	(mean,	SD) 254 −1.17	(1.17) 235 −1.27	(1.18)
Parasite	infection	(n,	%)
Helminth	(any	spp) 421 357	(84.8) 426 361	(84.7)
Hookworma 439 315	(71.8) 438 326	(74.4)
Necator americanus 439 310	(70.6) 438 324	(74.0)
Ancylostoma duodenale 439 27	(6.2) 438 23	(5.3)
Ascaris lumbricoidesa 439 154	(35.1) 438 146	(33.3)
Trichuris trichiurab 558 144	(25.8) 541 150	(20.2)
Total	IgE	(IU/ml	[GM,	95	CI]) 753 1372	(1239-	1519) 741 1340	(1210-	1485)
Interleukin-	5	production	in	
response	to	PHA	(pg/mL	[median,	
IQR])
374 511	(287-	777) 308 490	(291-	808)
adiagnosed	by	PCR.
bdiagnosed by microscopy.
TABLE  1 Baseline characteristics of the 
study population
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[95%	 CI]	 at	 9	months	 −0.071	 [-	0.112	 to	 −0.030],	 at	 21	months	
−0.060	[−0.099	to	−0.020];	overall	P-	value:	Ptime<.001).	When	infec-
tion	was	defined	as	 light	or	heavy	based	on	parasite-	specific	DNA	
loads	 of	 hookworm	 and	 A. lumbricoides at baseline, the estimated 
treatment effect on IgE levels was significant in subjects with a 
heavy	infection	at	baseline	(at	9	months	−0.074	[−0.142	to	−0.005],	
at	21	months	−0.083	[-	0.146	to	−0.019];	Ptime=.051).	In	subjects	with	
light infections, we observed no significant treatment effect on IgE 
(at	9	months	−0.039	[−0.126	to	0.047],	at	21	months	−0.001	[−0.08	
to	 0.079];	 ptime=0.664; P-	value	 for	 interaction=.252),	 nor	 in	 sub-
jects	who	were	uninfected	at	baseline	(at	9	months	−0.134	[−0.280	
to	0.012],	at	21	months	−0.040	 [−0.078	 to	0.158];	overall	P-	value:	
Ptime=	.140).
Similar	effects	of	treatment	on	IgE	levels	were	observed	in	children	
(at	9	months	−0.069	[−0.134	to		0.004],	at	21	months	−0.071	[−0.134	
to	 0.009];	 Ptime=.003)	 and	 adults	 (at	 9	months	 −0.070	 [−0.120	 to	
−0.021],	at	21	months	−0.053	[−0.099	to	−0.007];	Ptime=.006; P-	value	
for	 interaction=.876).	Albendazole	 treatment	 reduced	 total	 IgE	 to	 a	
similar	extent	 in	both	males	 (at	9	months	−0.038	[−0.102	to	0.025],	
at	21	months	−0.067	[−0.125	to	−0.009];	Ptime=.059)	and	females	(at	
9	months	−0.093	[−0.143	to	−0.042],	at	21	months	−0.055	[−0.103	to	
−0.007];	Ptime=.001; P-	value	for	interaction=.349).
3.5 | Baseline IL- 5 production in response to PHA
At	baseline,	we	detected	no	significant	difference	in	IL-	5	levels	to	PHA	
between	 subjects	 with	 light	 (474	 (242-	775)	pg/mL	 [median,	 IQR])	
and	heavy	infections	(490	(283-	801)	pg/mL)	(P=.364)	(Table	S1).	IL-	5	
responses	were	 significantly	 lower	 in	 adults	 (472	 (258-	728)	pg/mL)	
compared	to	children	(534	(319-	841)	pg/mL)	(P=.04).	When	consider-
ing	gender,	significantly	higher	levels	of	IL-	5	were	observed	in	males	
(588	(347-	884)	pg/mL)	compared	to	females	 (460	(259-	698)	pg/mL;	
P<.001).
3.6 | Effect of albendazole treatment on whole- 
blood IL- 5 responses to PHA
There	was	 no	 significant	 treatment	 effect	 on	 IL-	5	 production	 in	 re-
sponse	 to	 PHA	 at	 9	months	 (estimates	 [95%	 CI],	 0.037	 [−0.052	 to	
0.127]).	However,	we	observed	significantly	elevated	levels	of	IL-	5	to	
PHA	at	21	months	(0.107	[0.000	to	0.214]).	When	both	time	points	
were	taken	into	account,	the	overall	P-	value	over	time	fell	short	of	sta-
tistical	significance	(Ptime=.146).	IL-	5	measured	in	unstimulated	blood	
revealed	no	treatment-	related	differences	(data	not	shown).
Additionally,	we	observed	no	effect	of	treatment	on	IL-	5,	nor	dif-
ferences in the treatment effect between subgroups when subjects 
with	light	and	heavy	infections	(P-	value	for	interaction=.850)	or	chil-
dren	 and	 adults	 (P-	value	 for	 interaction=.998)	were	 analysed	 sepa-
rately.	In	males,	treatment	did	not	show	a	significant	effect	on	the	IL-	5	
response	(at	9	months	−0.027	[−0.163	to	0.108],	at	21	months	0.041	
[−0.135	to	0.218];	Ptime=.780),	whereas	a	trend	towards	an	increase	in	
IL-	5	response	was	observed	in	females	(at	9	months	0.086	[−0.031	to	
0.203],	at	21	months	0.164	[0.018	to	0.311];	Ptime=.192; P-	value	for	
interaction=.316).
F IGURE  1 Effect of deworming on the 
prevalence of helminth infections, total IgE 
levels	and	whole-	blood	IL-	5	production	in	
response	to	phytohaemagglutinin	(PHA).	
(A)	Percentage	of	helminth-	infected	
subjects	in	placebo-	and	albendazole-	
treated	arms.	The	estimated	effect	of	
albendazole	treatment	on	plasma	total	IgE	
levels	(B)	and	IL-	5	production	in	response	
to	PHA	in	supernatant	of	72	h-	stimulated	
whole-	blood	cultures	(C)	is	displayed	for	
the	9-	and	the	21-	month	time	points,	with	
corresponding 95% confidence intervals. 
The	estimates	of	the	treatment	effect	were	
obtained by general linear mixed models 
and overall P-	values	over	time	are	indicated.
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4  | DISCUSSION
This	is	the	first	time	that	the	effects	of	long-	term	placebo-	controlled	
anthelmintic	 treatment	 on	 different	 components	 of	 a	 helminth-	
induced	Th2	response	have	been	analysed	in	a	whole	community.	We	
show	a	significant	decline	in	plasma	IgE	levels	in	albendazole-	treated	
subjects	 over	 a	 period	 of	 21	months	 compared	 to	 placebo-	treated	
subjects.	However,	whereas	both	IgE	and	IL-	5	are	important	products	
of	the	helminth-	induced	Th2	response,	IL-	5	production	by	peripheral	
blood	cells	in	response	to	PHA	was	not	significantly	affected	by	an-
thelmintic treatment and rather tended to increase.
It	is	well	known	that	helminth	parasites	are	potent	inducers	of	IgE	
production.12-15	So	far,	only	a	few	longitudinal	studies	have	been	per-
formed to study the effect of anthelmintic treatment on polyclonal IgE 
levels.16-18	In	line	with	our	findings,	Cooper	et	al.	14 showed that 1 year 
of anthelmintic treatment was associated with a significant reduction 
in	total	 IgE	levels	 in	children,	suggesting	that	current	STH	infections	
are	 important	 determinants	 of	 IgE	 levels.	Whereas	 previous	 studies	
only included children below 12 years of age,14,16 in the current ran-
domized	 trial,	we	 studied	 the	 general	 population	 across	 all	 ages	 to	
show decreases in IgE levels in the whole community irrespective of 
age.
Overall, the treatment effect on IgE was seen at 9 months, and this 
effect remained at 21 months and IgE levels did not further decrease. 
The	major	effect	seen	on	IgE	after	9	months	probably	reflects	the	large	
decrease	 in	prevalence	of	hookworm	and	A. lumbricoides which was 
2.5-	 and	 2.3-	fold	 compared	 to	 baseline,	 respectively,	whereas	 after	
21	months,	 the	prevalence	of	both	species	decreased	1.4-	fold	com-
pared	to	9	months	post-	treatment.	The	lack	of	further	decrease	in	IgE	
at 21 months may be due to continued exposure to incoming parasites 
in	a	contaminated	environment,	which	would	stimulate	long-	lived	IgE	
plasma cells contributing to sustained IgE antibody production.14,19
Given	the	observed	treatment	effect	on	IgE,	it	would	appear	that	
deworming	decreases	Th2-	mediated	 responses.	However,	we	 found	
no	significant	effect	of	treatment	on	IL-	5	in	response	to	PHA	and	even	
a	trend	towards	increase	at	21	months	post-	treatment.	As	described	
elsewhere in more detail,10 analysis of uninfected subjects showed 
that	treatment	had	no	effect	on	IL-	5	production,	ruling	out	a	direct	ef-
fect	of	albendazole	on	immune	responses.	It	has	been	reported	before	
that	IL-	5	responses	may	be	suppressed	during	helminth	infections	and	
treatment	results	in	enhanced	helminth-	specific	and	unrelated	antigen	
responses.10,20-22
A	 study	 conducted	 in	 Kenya	 showed	 that	 in	 schoolchildren	 in-
fected with Schistosoma mansoni,	type	2	cytokine	responses	including	
IL-	4,	IL-	5,	IL-	9	and	IL-	13	were	significantly	increased	upon	stimulation	
with	 egg	 antigen	 1	 and	 2	years	 post-	treatment.23	Another	 study	 in	
Gabon	showed	that	 specifically	 IL-	5,	but	neither	 IL-	4	nor	 IL-	13,	was	
downregulated during an active S. haematobium	infection	as	only	IL-	5	
responses to worm antigens were increased in subjects who remained 
free from infection 2 years after helminth clearance, compared to sub-
jects who became re infected.22
This	enhanced	cytokine	response	can	be	due	to	either	removal	of	
the immunosuppressive effects of active infection or immunological 
boosting by antigens released from dying parasites.23	Although	 it	 is	
possible	 that	 treatment	 boosts	 the	 antigen-	specific	 responses,	 often	
also	responses	to	unrelated	antigens	such	as	PHA	are	enhanced	by	an-
thelmintic	treatment.	The	latter	cannot	be	explained	by	helminth	anti-
gens	boosting	specific	T-	cell	responses,	unless	it	is	due	to	cross-	reactive	
antigen responses that are enhanced in these unrelated antigens.10,21
As	 anthelmintic	 treatment	 appears	 to	 have	 opposite	 effects	 on	
type	2	cytokine	production	and	total	IgE,	and	IL-	4	and	IL-	13	promote	
IgE	production,	this	raises	the	question	whether	there	are	IL-	4/IL-	13	
independent	 pathways	 of	 IgE	 regulation.	T-	cell-	independent	 IgE+	 B-	
cell maturation in tissues has been described, suggesting that IgE class 
switching	does	not	fully	depend	on	Th2	cytokine	levels.24 Perhaps IgE 
memory	B	 cells	 and/or	 long-	lived	 IgE	plasma	 cells	 can	maintain	 the	
production	 of	 IgE	 via	 Th2	 cytokine-	independent	 pathways,	 concur-
rent	 to	Th2	 cells	 becoming	 hyporesponsive	 and	 producing	 less	Th2	
cytokines.	However,	as	there	is	very	little	data	from	human	studies	on	
IgE memory B cells and the pathways by which IgE is regulated, this 
remains a speculation.
T	follicular	helper	(Tfh)	cells,	a	subset	of	CD4+	T	cells	that	migrates	
to	B-	cell	follicles	and	induces	antibody	production	by	B	cells,25 have 
been	described	as	 the	dominant	source	of	 IL-	4	 in	vivo	during	 infec-
tion with Heligmosomoides polygyrus.26	 In	 humans,	 the	 frequencies	
of	total	and	activated	peripheral	memory	Tfh	cells	were	found	to	be	
significantly increased during S. japonicum infection.27	Although	 it	 is	
currently	unknown	what	happens	to	Tfh	cell	numbers	after	helminth	
clearance, decreasing numbers could possibly explain the observed 
decline	in	total	IgE	after	treatment,	as	this	would	lead	to	less	IL-	4	pro-
duction	in	B-	cell	follicles,	hence	less	IgE	secretion.
Based on our findings, we could conclude that 2 years of anthel-
mintic	treatment	might	have	differential	effects	on	Th2	responses.	IgE	
responses	are	elevated	in	helminth-	infected	subjects	and	decline	after	
intensive	 deworming,	 whereas	 IL-	5	 production	 by	 peripheral	 blood	
cells seems suppressed in infected subjects and might be reversed 
after deworming. Both phenomena have separately been reported by 
others, and here we report the occurrence of both within one commu-
nity.	These	differential	effects	on	responses	typified	as	Th2-	mediated	
need	to	be	taken	into	account	when	examining	the	effects	of	helminths	
on	noncommunicable	diseases.	The	concern	that	upon	deworming,	in-
flammatory diseases such as allergies could increase, might be justified 
if	we	look	at	Th2	cytokines,	but	not	if	one	considers	IgE.	However,	it	
is	also	known	that	IgE	responses	during	helminth	infection	are	domi-
nated by antibodies that have poor biological activity28 and therefore, 
a decrease in IgE that is not functional might still be in line with a rela-
tive increase in IgE that can trigger mast cell degranulation.
It would be interesting to complement these findings with data on 
eosinophilia	and	other	Th2	cytokine	responses	such	as	IL-	4	and	IL-	13,	
in	order	to	further	 investigate	helminth’s	 immunomodulatory	effects	
on	Th2	responses.
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